Pierrick Martinez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pierrick Martinez has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Enrique A. Martinez Mosqueira
Oasis Santé, Medical Center, 30700 Uzès, France
3 shared publications - Antonio Vega-Gálvez
Food Engineering Department, Universidad de La Serena, Av. Raúl Bitrán 1305, La Serena 1700000, Chile
2 shared publications - Manuel Aparicio-Alonso
Centro Médico Jurica, Mexico
2 shared publications Casey Peavler
Holy Cross Health, 4725 N Federal Hwy, Fort Lauderdale, FL 33308, USA
1 shared publicationFabrice Joulia
Laboratory « Jeunesse - Activité Physique et Sportive, Santé »(J-AP2S), University of Toulon, Toulon, France; Center for Cardiovascular and Nutrition Research C2VN, INSERM 1263 INRAE 1260 Aix Marseille Université, Marseille, France
1 shared publication- Fabrice Joulia
Laboratoire Jeunesse-Activité Physique et Sportive-Santé (J-AP2S), Univ Toulon, 83041 Toulon, France
1 shared publication
Latest Publications
- Open Access
- 28 June 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (7) , 809
The Redox Paradox of Natural Supplements in Cancer: A Narrative Review to Guide Clinical Practice
Supplements are widely perceived as safe and beneficial; yet in oncology, this assumption is questionable. Clinical trials over the past few decades have often produced disappointing results, raising a critical question: are these agents used correctly, or could they inadvertently cause harm? This review examines supplements frequently used in cancer care—such as oral vitamin C, berberine, N-acetylcysteine, vitamin D, vitamin E, melatonin, polyphenols, alpha-lipoic acid, selenium, and coenzyme Q10—which can act as tumor suppressors or promoters depending on dose, route, and disease stage. We examine their dual antioxidant and pro-oxidant properties, revealing that therapeutic outcomes are shaped not only by the molecule itself, but also by bioavailability, dosing thresholds, and the tumor redox environment. Building on these insights, we propose that four factors may be considered to guide clinical use: ensure that anticancer effects are not overshadowed by antioxidant activity, achieve sufficient bioavailability, confirm pro-oxidant concentrations where possible, and prioritize supplements that target the respiration-supported non-OxPhos pathways. By framing supplements as context-dependent redox modulators rather than universally beneficial agents, this review provides a mechanistically grounded framework for informing future research and safer, more effective integrative oncology strategies.
- 28 June 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (7) , 809
Open AccessThe Redox Paradox of Natural Supplements in Cancer: A Narrative Review to Guide Clinical Practice
Supplements are widely perceived as safe and beneficial; yet in oncology, this assumption is questionable. Clinical trials over the past few decades have often produced disappointing results, raising a critical question: are these agents used correctly, or could they inadvertently cause harm? This review examines supplements frequently used in cancer care—such as oral vitamin C, berberine, N-acetylcysteine, vitamin D, vitamin E, melatonin, polyphenols, alpha-lipoic acid, selenium, and coenzyme Q10—which can act as tumor suppressors or promoters depending on dose, route, and disease stage. We examine their dual antioxidant and pro-oxidant properties, revealing that therapeutic outcomes are shaped not only by the molecule itself, but also by bioavailability, dosing thresholds, and the tumor redox environment. Building on these insights, we propose that four factors may be considered to guide clinical use: ensure that anticancer effects are not overshadowed by antioxidant activity, achieve sufficient bioavailability, confirm pro-oxidant concentrations where possible, and prioritize supplements that target the respiration-supported non-OxPhos pathways. By framing supplements as context-dependent redox modulators rather than universally beneficial agents, this review provides a mechanistically grounded framework for informing future research and safer, more effective integrative oncology strategies.
- Open Access
Methemoglobin Activity Might Explain Rapid Increase in Oxygen Saturation Among COVID-19 Patients Healed with Chlorine Dioxide Gas in Solution
Chlorine dioxide (ClO2) is a neutral oxidant molecule with a short lifespan once in contact with electron donors (organic matter). ClO2 solutions have antiviral, antibacterial, antifungal, anti-protozoan, anti-inflammatory, anticancer, and wound-healing activity and it was used at safe concentrations on patients from different countries during the COVID-19 pandemic. In Mexico, 1067 COVID-19 patients received compassionate treatments with ClO2 during the 2020/2021 pandemic years. We describe the treatments and clinical reports of these patients, as it concerns the oxygen saturation (SpO2) recovery, and provide a biochemical explanation. The number of healed patients was 1057, >99% of the total and SpO2 showed a hyperbolic fast increase. This might happen because ClO2 attracts one electron from the organic matter and produces a chlorite anion (). This new molecule is known to exhibit metabolic activity in the blood stream. On the one hand, it will perform the aforementioned antibiotic and healing properties. On the other hand, it will also allow the production of oxygen (O2) to be transported by the Oxyhemoglobin. This reaction is mediated by an intermediate state of a ferryl molecule (Fe=O) in the allosteric heme site of methemoglobin, which behaves as a reductase enzyme. This reaction can explain the rapid and steady increase in O2 saturation in healed patients.Open AccessMethemoglobin Activity Might Explain Rapid Increase in Oxygen Saturation Among COVID-19 Patients Healed with Chlorine Dioxide Gas in Solution
Chlorine dioxide (ClO2) is a neutral oxidant molecule with a short lifespan once in contact with electron donors (organic matter). ClO2 solutions have antiviral, antibacterial, antifungal, anti-protozoan, anti-inflammatory, anticancer, and wound-healing activity and it was used at safe concentrations on patients from different countries during the COVID-19 pandemic. In Mexico, 1067 COVID-19 patients received compassionate treatments with ClO2 during the 2020/2021 pandemic years. We describe the treatments and clinical reports of these patients, as it concerns the oxygen saturation (SpO2) recovery, and provide a biochemical explanation. The number of healed patients was 1057, >99% of the total and SpO2 showed a hyperbolic fast increase. This might happen because ClO2 attracts one electron from the organic matter and produces a chlorite anion (). This new molecule is known to exhibit metabolic activity in the blood stream. On the one hand, it will perform the aforementioned antibiotic and healing properties. On the other hand, it will also allow the production of oxygen (O2) to be transported by the Oxyhemoglobin. This reaction is mediated by an intermediate state of a ferryl molecule (Fe=O) in the allosteric heme site of methemoglobin, which behaves as a reductase enzyme. This reaction can explain the rapid and steady increase in O2 saturation in healed patients. - Open Access
- 2 April 2026
- Published by MDPI AG in Preprints.org
Methemoglobin Activity Explains Rapid Increase in Oxygen Saturation Among COVID-19 Patients Healed with Chlorine Dioxide Gas in Solution
Chlorine Dioxide (ClO2) is a neutral oxidant molecule having a short life-span once in contact with electron donors (organic matter). ClO2 solutions have antiviral, antibiotic, anti-inflammatory, anticancer and wound healing activity and it was used at safe concentrations with patients of different countries during the COVID-19 pandemic. In Mexico 1067 COVID-19 patients received compassionate treatments with ClO2 during the 2020/2021 pandemic years. We describe the treatments and clinical report of these patients, as it concerns the Oxygen saturation (SpO2) recovery and we give a biochemical explanation. The number of healed patients was 1057, >99% of the total and SpO2 showed a hyperbolic fast increase. This happens because ClO2 attracts one electron from the organic matter and produces a Chlorite anion (ClO2-). This new molecule has a known metabolic activity in the blood stream. On the one side, it will have the mentioned anti-viral, antibiotic and on the other side it will also allow producing Oxygen (O2) to be transported by the hemoglobin. This reaction is mediated by an intermediate state of a Ferryl molecule (Fe=O) in the allosteric site of methemoglobin, which behaves as a reductase enzyme. This reaction explains the rapid and steady increase of O2-saturation in healed patients.
- 2 April 2026
- Published by MDPI AG in Preprints.org
Open AccessMethemoglobin Activity Explains Rapid Increase in Oxygen Saturation Among COVID-19 Patients Healed with Chlorine Dioxide Gas in Solution
Chlorine Dioxide (ClO2) is a neutral oxidant molecule having a short life-span once in contact with electron donors (organic matter). ClO2 solutions have antiviral, antibiotic, anti-inflammatory, anticancer and wound healing activity and it was used at safe concentrations with patients of different countries during the COVID-19 pandemic. In Mexico 1067 COVID-19 patients received compassionate treatments with ClO2 during the 2020/2021 pandemic years. We describe the treatments and clinical report of these patients, as it concerns the Oxygen saturation (SpO2) recovery and we give a biochemical explanation. The number of healed patients was 1057, >99% of the total and SpO2 showed a hyperbolic fast increase. This happens because ClO2 attracts one electron from the organic matter and produces a Chlorite anion (ClO2-). This new molecule has a known metabolic activity in the blood stream. On the one side, it will have the mentioned anti-viral, antibiotic and on the other side it will also allow producing Oxygen (O2) to be transported by the hemoglobin. This reaction is mediated by an intermediate state of a Ferryl molecule (Fe=O) in the allosteric site of methemoglobin, which behaves as a reductase enzyme. This reaction explains the rapid and steady increase of O2-saturation in healed patients.
- 15 March 2025
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 334, 104416
Breath-hold diving as a tool to harness a beneficial increase in cardiac vagal tone
- 15 March 2025
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 334, 104416
Breath-hold diving as a tool to harness a beneficial increase in cardiac vagal tone
- Open Access
- 3 March 2025
- Published by Walter de Gruyter GmbH in Journal of Osteopathic Medicine
- Vol. 125 (8) , 379-388
Impact of osteopathic tests on heart rate and heart rate variability: an observational study on osteopathic students
Context: Osteopathic listening tests are diagnostic tools utilized in manual therapies, but their impact on physiological markers of the autonomic nervous system (ANS), such as heart rate (HR) and heart rate variability (HRV), remains unclear. This study examines these effects to clarify the role of listening tests within osteopathic practice. Objectives: This study aims to evaluate the influence of osteopathic listening tests on HR and HRV markers, including the root mean square of successive differences (rMSSD) and the low-frequency/high-frequency (LF/HF) ratio, in healthy participants, and to contextualize the findings within existing osteopathic research on ANS modulation. Methods: 51 osteopathic students were randomized into three groups: (1) an osteopathic test group (OTG) receiving listening tests; (2) a light pressure group (LPG) experiencing non-therapeutic light pressure; and (3) a control group (CG) receiving no intervention. Measurements of HR, rMSSD, and LF/HF ratio were collected during the first and last 30 s of the protocol utilizing validated software. Data from 48 participants were analyzed after excluding artifacts. Results: No significant changes in HR, rMSSD, or LF/HF ratio were observed in any group during the protocol. For OTG, the HR changed minimally (69.17 ± 9.58 beats per minute [bpm] to 69.10 ± 10.24 bpm; p=0.884), while the rMSSD and LF/HF ratio also showed no significant alterations (p=0.064 and p=0.106, respectively). Similar null findings were observed in the LPG and CG, suggesting that neither osteopathic tests nor light pressure induced measurable effects on the ANS markers chosen. Conclusions: This study found no evidence that osteopathic listening tests influence HR or HRV markers in healthy participants. Although listening tests serve as diagnostic tools for identifying somatic dysfunctions, they do not appear to exert therapeutic effects on ANS regulation. These findings contrast with previous studies on osteopathic manipulative treatment (OMT), which have demonstrated significant modulation of ANS activity. Future studies should investigate the differential effects of diagnostic tests and therapeutic techniques to better define the scope of the osteopathic interventions.
- 3 March 2025
- Published by Walter de Gruyter GmbH in Journal of Osteopathic Medicine
- Vol. 125 (8) , 379-388
Open AccessImpact of osteopathic tests on heart rate and heart rate variability: an observational study on osteopathic students
Context: Osteopathic listening tests are diagnostic tools utilized in manual therapies, but their impact on physiological markers of the autonomic nervous system (ANS), such as heart rate (HR) and heart rate variability (HRV), remains unclear. This study examines these effects to clarify the role of listening tests within osteopathic practice. Objectives: This study aims to evaluate the influence of osteopathic listening tests on HR and HRV markers, including the root mean square of successive differences (rMSSD) and the low-frequency/high-frequency (LF/HF) ratio, in healthy participants, and to contextualize the findings within existing osteopathic research on ANS modulation. Methods: 51 osteopathic students were randomized into three groups: (1) an osteopathic test group (OTG) receiving listening tests; (2) a light pressure group (LPG) experiencing non-therapeutic light pressure; and (3) a control group (CG) receiving no intervention. Measurements of HR, rMSSD, and LF/HF ratio were collected during the first and last 30 s of the protocol utilizing validated software. Data from 48 participants were analyzed after excluding artifacts. Results: No significant changes in HR, rMSSD, or LF/HF ratio were observed in any group during the protocol. For OTG, the HR changed minimally (69.17 ± 9.58 beats per minute [bpm] to 69.10 ± 10.24 bpm; p=0.884), while the rMSSD and LF/HF ratio also showed no significant alterations (p=0.064 and p=0.106, respectively). Similar null findings were observed in the LPG and CG, suggesting that neither osteopathic tests nor light pressure induced measurable effects on the ANS markers chosen. Conclusions: This study found no evidence that osteopathic listening tests influence HR or HRV markers in healthy participants. Although listening tests serve as diagnostic tools for identifying somatic dysfunctions, they do not appear to exert therapeutic effects on ANS regulation. These findings contrast with previous studies on osteopathic manipulative treatment (OMT), which have demonstrated significant modulation of ANS activity. Future studies should investigate the differential effects of diagnostic tests and therapeutic techniques to better define the scope of the osteopathic interventions.
- 13 February 2025
- Published by Elsevier in Cancer Letters
- Vol. 617, 217539
Malignant tumors in vagal-innervated organs: Exploring its homeostatic role
- 13 February 2025
- Published by Elsevier in Cancer Letters
- Vol. 617, 217539
Malignant tumors in vagal-innervated organs: Exploring its homeostatic role
- RetractedOpen Access
- 1 January 2025
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 18 (1) , 856-863
Fenbendazole as an Anticancer Agent? A Case Series of Self-Administration in Three Patients
Background: Fenbendazole (FBZ), an inexpensive and widely accessible antiparasitic drug used in veterinary medicine, has garnered growing interest for its potential as an anticancer therapy. Preclinical studies suggest that FBZ exerts its anticancer effects through a wide variety of mechanisms. While FBZ has shown promise both in vitro and in vivo studies, clinical evidence supporting its use and efficacy in treating metastatic cancer is currently limited. Case Presentations: This report highlights 3 cases of patients with advanced cancer – including breast, prostate, and melanoma. Two patients achieved complete remission, and one achieved near-complete remission after incorporating FBZ into their treatment regimens alongside other therapies (excluding chemotherapy). All three patients tolerated FBZ without any reported adverse effects, and remission was sustained during follow-up periods ranging from 11 months to nearly 3 years. Conclusion: FBZ demonstrates potential as a novel promising therapeutic option for repurposing in oncology. Its ability to contribute to tumor regression and achieve disease remission warrants further clinical research to establish its efficacy and optimize its use.
- 1 January 2025
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 18 (1) , 856-863
RetractedOpen AccessFenbendazole as an Anticancer Agent? A Case Series of Self-Administration in Three Patients
Background: Fenbendazole (FBZ), an inexpensive and widely accessible antiparasitic drug used in veterinary medicine, has garnered growing interest for its potential as an anticancer therapy. Preclinical studies suggest that FBZ exerts its anticancer effects through a wide variety of mechanisms. While FBZ has shown promise both in vitro and in vivo studies, clinical evidence supporting its use and efficacy in treating metastatic cancer is currently limited. Case Presentations: This report highlights 3 cases of patients with advanced cancer – including breast, prostate, and melanoma. Two patients achieved complete remission, and one achieved near-complete remission after incorporating FBZ into their treatment regimens alongside other therapies (excluding chemotherapy). All three patients tolerated FBZ without any reported adverse effects, and remission was sustained during follow-up periods ranging from 11 months to nearly 3 years. Conclusion: FBZ demonstrates potential as a novel promising therapeutic option for repurposing in oncology. Its ability to contribute to tumor regression and achieve disease remission warrants further clinical research to establish its efficacy and optimize its use.
- Open Access
- 17 April 2024
- Published by MDPI AG in Metabolites
- Vol. 14 (4) , 229
Mitochondrial–Stem Cell Connection: Providing Additional Explanations for Understanding Cancer
The cancer paradigm is generally based on the somatic mutation model, asserting that cancer is a disease of genetic origin. The mitochondrial–stem cell connection (MSCC) proposes that tumorigenesis may result from an alteration of the mitochondria, specifically a chronic oxidative phosphorylation (OxPhos) insufficiency in stem cells, which forms cancer stem cells (CSCs) and leads to malignancy. Reviewed evidence suggests that the MSCC could provide a comprehensive understanding of all the different stages of cancer. The metabolism of cancer cells is altered (OxPhos insufficiency) and must be compensated by using the glycolysis and the glutaminolysis pathways, which are essential to their growth. The altered mitochondria regulate the tumor microenvironment, which is also necessary for cancer evolution. Therefore, the MSCC could help improve our understanding of tumorigenesis, metastases, the efficiency of standard treatments, and relapses.
- 17 April 2024
- Published by MDPI AG in Metabolites
- Vol. 14 (4) , 229
Open AccessMitochondrial–Stem Cell Connection: Providing Additional Explanations for Understanding Cancer
The cancer paradigm is generally based on the somatic mutation model, asserting that cancer is a disease of genetic origin. The mitochondrial–stem cell connection (MSCC) proposes that tumorigenesis may result from an alteration of the mitochondria, specifically a chronic oxidative phosphorylation (OxPhos) insufficiency in stem cells, which forms cancer stem cells (CSCs) and leads to malignancy. Reviewed evidence suggests that the MSCC could provide a comprehensive understanding of all the different stages of cancer. The metabolism of cancer cells is altered (OxPhos insufficiency) and must be compensated by using the glycolysis and the glutaminolysis pathways, which are essential to their growth. The altered mitochondria regulate the tumor microenvironment, which is also necessary for cancer evolution. Therefore, the MSCC could help improve our understanding of tumorigenesis, metastases, the efficiency of standard treatments, and relapses.